Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,576.81
(
-0.72%
)
US TECH 100
23,597.60
(
-0.83%
)
Dow Jones
45,814.19
(
-0.89%
)
Brent Oil
105.43
(
-1.08%
)
Bitcoin
69,699.44
(
-2.16%
)
News Focus
News Focus
Post# of 257259
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122799
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 187217

Tuesday, 04/25/2017 12:46:12 PM

Tuesday, April 25, 2017 12:46:12 PM

Post# of 257259
Merck KGaA sells FoB business to FRE.DE:

http://news.emdgroup.com/N/0/327E1F6634B69914C125810C005A3048/$File/PR_Biosimilars_24042017_US.pdf

Merck KGaA, Darmstadt…today announced the divestment of its Biosimilars business to Fresenius. The decision to divest Biosimilars is aligned with the company’s strategy for its Healthcare business sector to focus on its pipeline of innovative medicines.

According to the terms agreed for the transaction, Merck KGaA, Darmstadt, Germany will receive an upfront payment of €170 million, milestone payments of up to €500 million, plus royalties on future product sales.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now